+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
FEMALE
ID04710797

Study Comparing Complete Staging Surgery With and Without Lymph Node Removal in Early-Stage Ovarian Cancer

Led by Sun Yat-sen University · Updated on 2021-01-15

656

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of comprehensive staging surgery with and without lymphadenectomy in women with early-stage epithelial ovarian cancer, specifically FIGO stage IA to IIA. This randomized phase III study aims to compare the safety and effectiveness of these two surgical approaches on survival and quality of life. The study is designed to better understand whether omitting lymphadenectomy impacts patient outcomes, including progression-free survival and overall survival. Participants will be assigned to one of two surgical groups either comprehensive staging surgery without lymphadenectomy or completion staging surgery including systematic pelvic and para-aortic lymphadenectomy. Both approaches involve open or minimally invasive surgery, cytologic examinations, removal of the ovaries and uterus, and omentectomy. The lymphadenectomy group will have extensive removal of lymph nodes in pelvic and para-aortic areas, while the no lymphadenectomy group will have visual inspection and biopsy of suspicious lymph nodes only. Adjuvant chemotherapy will be given following national guidelines. During the study, participants will be followed every three months for the first two years, then every six months thereafter. Researchers will assess progression-free survival, overall survival, quality of life at baseline, six months, and one year post-surgery, postoperative complications, and lymph node recurrence rates over three years. The total study duration allows monitoring of long-term outcomes up to 100 months. Participants will undergo regular evaluations to track their health and recovery throughout the trial.

CONDITIONS

Brief Title

Lymphadenectomy in Early Ovarian Cancer

Research Team

J

Jihong Liu, Ph.D.

T

Ting Deng, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here